........at the 2 Annual European Investing and Partnering Summit to be held September 4-5 in Helsinki, Finland, which is being hosted by NeuroInsights. The presentation will focus on the science, data and development strategy for the LymPro Test(R) for Alzheimer's disease (AD) which is being advanced based on the ectopic cell cycle re-entry ("CCR" or "cell cycle dysfunction") hypothesis of AD.
@nose, durchaus möglich !! |